SCHEMBL3583284

SCHEMBL3583284

CNc1ccccc1C(=O)NCc1ccc(C(F)(F)F)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 1/20 0.54
LSS P48449 1/20 0.53
SORT1 Q99523 1/20 0.52
KDM4E B2RXH2 3/20 0.51
ALDH1A1 P00352 2/20 0.51
HPGD P15428 1/20 0.51
HSD17B10 Q99714 1/20 0.51
MT-CO2 P00403 3/20 0.50
HDAC6 Q9UBN7 1/20 0.50
MAPK1 P28482 1/20 0.50
APEX1 P27695 1/20 0.50
MTTP P55157 1/20 0.49
PPARA Q07869 3/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
ABL1 P00519 1/20 0.48
EGFR P00533 1/20 0.48
CSF1R P07333 1/20 0.48
PDGFRB P09619 1/20 0.48
KIT P10721 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3576438 0.90 KDM4E (0.49) MAPK14KDM4EALDH1A1HPGDHSD17B10
SCHEMBL3576770 0.90 MT-CO2 (0.49) MAPK14KDM4EALDH1A1HPGDHSD17B10
SCHEMBL13932577 0.84 KDM4E (0.65) KDM4EALDH1A1HPGDHSD17B10MT-CO2
SCHEMBL3575043 0.83 EPHX2 (0.57) MAPK14KDM4EALDH1A1HPGDHSD17B10
SCHEMBL8404892 0.82 NPC1 (0.62) MAPK14LSSSORT1HDAC6APEX1
SCHEMBL3577180 0.81 KDM4E (0.68) MAPK14LSSSORT1KDM4EALDH1A1
SCHEMBL6356701 0.81 MAPK14 (0.56) MAPK14LSSSORT1ALDH1A1HPGD
SCHEMBL4663813 0.80 HPGD (0.72) HPGDPPARAPPARG
SCHEMBL3580203 0.78 MAPK14 (0.60) MAPK14KDM4EALDH1A1HPGDHSD17B10
SCHEMBL2634030 0.78 MAPK14 (0.76) MAPK14LSSHDAC6PPARAEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7678818-B2 Anthranilamide and 2-amino-heteroarene-carboxamide compounds HOFFMANN-LA ROCHE INC. (US) 2010-03-16 US disclosed
US-20070219261-A1 Anthranilamide and 2-amino-heteroarene-carboxamide compounds HOFFMANN-LA ROCHE INC. 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070219261-A1 Anthranilamide and 2-amino-heteroarene-carboxamide compounds AADAT, AAAS, AADAC MAPK14 2731/4885LSS 1473/4885SORT1 4547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.